The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical development

被引:110
作者
Bailey, CA
Bryla, P
Malick, AW
机构
[1] Pharmaceutical Res. and Development, Hoffmann La-Roche Inc., Nutley
[2] Bayer Corporation, West Haven
关键词
Caco-2; permeability; partition coefficient; peptide transporters; formulation development; tissue culture;
D O I
10.1016/S0169-409X(96)00416-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The need for more innovative and readily orally bioavailable therapeutics that can be developed faster has driven the development of tools and strategies that will have a major impact on those needs. The application of the Caco-2 human epithelial cell line for use as a tissue culture model for permeability measurements that can be used to predict oral absorption effectively demonstrates this strategy. This article discusses some applications of the Caco-2 tissue culture model in pharmaceutical development. The development of an experimental program to characterize the endogenous gut peptide transport system is described, as well as its application to the understanding of the oral absorption of cephalosporin molecules. Other studies describe the use of permeability studies for a chemical series of drug candidates to predict their oral absorption in vivo. Finally, the application of the model to aid in the development of formulation strategies is discussed.
引用
收藏
页码:85 / 103
页数:19
相关论文
共 33 条
[1]   SELECTIVE PARACELLULAR PERMEABILITY IN 2 MODELS OF INTESTINAL-ABSORPTION - CULTURED MONOLAYERS OF HUMAN INTESTINAL EPITHELIAL-CELLS AND RAT INTESTINAL SEGMENTS [J].
ARTURSSON, P ;
UNGELL, AL ;
LOFROTH, JE .
PHARMACEUTICAL RESEARCH, 1993, 10 (08) :1123-1129
[2]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[3]   THE USE OF CULTURED EPITHELIAL AND ENDOTHELIAL-CELLS FOR DRUG TRANSPORT AND METABOLISM STUDIES [J].
AUDUS, KL ;
BARTEL, RL ;
HIDALGO, IJ ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :435-451
[4]  
Bailey C. A., 1994, Pharmaceutical Research (New York), V11, pS202
[5]  
BAILEY C A, 1991, Pharmaceutical Research (New York), V8, pS218
[6]   COMMON CHARACTERISTICS FOR NA+-DEPENDENT SUGAR-TRANSPORT IN CACO-2 CELLS AND HUMAN-FETAL COLON [J].
BLAIS, A ;
BISSONNETTE, P ;
BERTELOOT, A .
JOURNAL OF MEMBRANE BIOLOGY, 1987, 99 (02) :113-125
[7]   CEFACLOR UPTAKE BY THE PROTON-DEPENDENT DIPEPTIDE TRANSPORT CARRIER OF HUMAN INTESTINAL CACO-2 CELLS AND COMPARISON TO CEPHALEXIN UPTAKE [J].
DANTZIG, AH ;
TABAS, LB ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1112 (02) :167-173
[8]   UPTAKE OF THE CEPHALOSPORIN, CEPHALEXIN, BY A DIPEPTIDE TRANSPORT CARRIER IN THE HUMAN INTESTINAL-CELL LINE, CACO-2 [J].
DANTZIG, AH ;
BERGIN, L .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1027 (03) :211-217
[9]  
DIX CJ, 1987, BIOCHEM SOC T, V15, P443
[10]   STRUCTURAL REQUIREMENTS FOR INTERACTION WITH THE OLIGOPEPTIDE TRANSPORTER IN CACO-2 CELLS [J].
HIDALGO, IJ ;
BHATNAGAR, P ;
LEE, CP ;
MILLER, J ;
CUCULLINO, G ;
SMITH, PL .
PHARMACEUTICAL RESEARCH, 1995, 12 (02) :317-319